Yu Robinson K, Lagemann Gerritt M, Ghodadra Anish, Agarwal Vikas
Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
J Spine Surg. 2016 Dec;2(4):246-255. doi: 10.21037/jss.2016.09.04.
Lumbar transforaminal epidural steroid injection is a common and effective tool for managing lumbar radicular pain, although accidental intravascular injection can rarely result in paralysis. The purpose of this study is to determine the safest needle tip position for computed tomography (CT)-guided lumbar transforaminal epidural steroid injections as determined by incidence of intravascular injection.
Three radiologists, in consensus, reviewed procedural imaging for consecutive CT-fluoroscopic lumbar transforaminal epidural steroid injections performed during a 16-month period. Intravascular injections were identified and categorized by needle tip position, vessel type injected, intravascular injection volume and procedural phase containing the intravascular injection. Pearson chi-square and logistic regression testing were used to assess differences between groups, as appropriate.
Intravascular injections occurred in 9% (52/606) of injections. The intravascular injection rate was significantly lower (P<0.001) for extraforaminal needle position (0%, 0/109) compared to junctional (8%, 27/319) and foraminal (14%, 25/178) needle tip positions. Of the intravascular injections, 4% (2/52) were likely arterial, 35% (18/52) were likely venous, and 62% (32/52) were indeterminate for vessel type injected. 46% (24/52) of intravascular injections were large volume, 33% (17/52) were small volume, and 21% (11/52) were trace volume. 56% (29/52) of intravascular injections occurred with the contrast trial dose, 29% (15/52) with the steroid/analgesic cocktail, and 15% (8/52) with both.
An extraforaminal needle position for CT-fluoroscopic lumbar transforaminal epidural steroid injections decreases the risk of intravascular injection and therefore may be safer than other needle tip positions.
腰椎经椎间孔硬膜外类固醇注射是治疗腰椎神经根性疼痛的一种常用且有效的方法,尽管意外血管内注射很少会导致瘫痪。本研究的目的是根据血管内注射的发生率,确定计算机断层扫描(CT)引导下腰椎经椎间孔硬膜外类固醇注射最安全的针尖位置。
三位放射科医生共同回顾了在16个月期间连续进行的CT透视引导下腰椎经椎间孔硬膜外类固醇注射的程序影像。根据针尖位置、注射的血管类型、血管内注射量以及包含血管内注射的程序阶段,对血管内注射进行识别和分类。酌情使用Pearson卡方检验和逻辑回归检验来评估组间差异。
血管内注射发生在9%(52/606)的注射中。与关节处(8%,27/319)和椎间孔内(14%,25/178)针尖位置相比,椎间孔外针尖位置的血管内注射率显著更低(P<0.001)(0%,0/109)。在血管内注射中,4%(2/52)可能是动脉注射,35%(18/52)可能是静脉注射,62%(32/52)的注射血管类型不确定。46%(24/52)的血管内注射为大容量,33%(17/52)为小容量,21%(11/52)为微量。56%(29/52)的血管内注射发生在造影剂试验剂量时,29%(15/52)发生在类固醇/镇痛混合剂注射时,15%(8/52)在两者注射时均发生。
CT透视引导下腰椎经椎间孔硬膜外类固醇注射采用椎间孔外针尖位置可降低血管内注射风险,因此可能比其他针尖位置更安全。